In February 2002, the National Vaccine Advisory Committee (NVAC)
convened a workshop discussion to evaluate the problems of vaccine
supply and prepare a report on strengthening the supply of
routinely recommended vaccines in the United States.
The 2002 meeting identified both immediate and contributing factors
to the vaccine supply disruptions in 2001. The summary report
outlined a number of strategies, by which the existing system could
be improved, including the following:
The purpose of this follow-up workshop is to bring stakeholders
together to: develop a progress report on the recommendations made
in 2002; identify both continuing and new factors that may threaten
a stable vaccine supply; and outline specific actions that can have
a durable effect in resolving impediments to the consistent and
reliable availability of licensed vaccines.
Monday, January 24th, 2005
|
1:00 PM |
Introduction: Purpose and Goals |
Charles Helms (NVAC) [PPT - 81KB] |
1:15 PM |
Welcome from HHS |
RADM Arthur Lawrence
(Assistant Surgeon General) |
1:30 PM |
Strategy: Regulatory Processes [PPT - 160KB]
Moderator: Walter Orenstein |
Norman Baylor (FDA) [PPT - 230KB]
Alan Shaw (Merck)
Lance Gordon (VaxGen) [PPT - 74KB]
Peter Paradiso (Wyeth) [PPT - 224KB]
|
2:30 PM |
Discussion & Public Comment |
|
3:00 PM |
- Break - |
|
3:15 PM |
Strategy: Utilizing Vaccine Stockpiles [PPT - 250KB]
Moderator: Stephen Cochi |
Eddie Wilder (CDC) [PPT - 284KB]
Phil Hosbach (sanofi pasteur) [PPT - 388KB] |
4:15 PM |
Strategy: Liability Issues
Moderator: Geoff Evans |
Mark Rogers (Department of Justice) [PPT - 1.9MB]
Randy Moss (Wilmer Cutler Pickering Hale and Dorr)
John Salamone (Consumer Advocate) |
5:15 PM |
Discussion & Public Comment |
|
5:45 PM |
- Adjourn - |
|
3:00 PM |
- Break - |
|
Tuesday, January 25th, 2005 |
9:00 AM |
Strategy: Increasing Financial Incentives for Research,
Development, Production and Administration [PPT - 792KB]
Moderator: Martin Myers |
|
9:15 AM |
CDC Perspective |
Stephen Cochi (CDC) [PPT - 1.97MB] |
9:30 AM |
CDC Perspective |
Randy Farris (Centers for Medicaid and Medicare Services) [PPT - 92KB] |
9:45 AM |
State & Local Perspective |
Richard Raymond (Assoc. of State and Territorial Health Offices) [DOC - 67KB] |
10:00 AM |
Health Plans Perspective |
Robert Scalettar (America's Health Insurance Plans) [PPT - 108KB] |
10:15 AM |
Provider Perspective |
Robert Siegel (St. Luke Pediatric Centers) [PPT - 455KB] |
10:30 AM |
Discussion & Public Comment |
|
11:00 AM |
- Break - |
|
|
Strategy: Increasing Financial Incentives for Research,
Development, Production and Administration (continued)
Moderator: Martin Myers
|
|
11:15 AM |
An Economists View |
Frank Sloan (Duke University) [PPT - 79KB] |
11:30 AM |
Industry Perspective |
Andrew Macknight (GlaxoSmithKline) [PPT - 7.59MB] |
11:45 AM |
Project BioShield:
A Model for Civilian Vaccines? |
Monique Mansoura (HHS) [PPT - 1.87MB |
12:00 PM |
Discussion & Public Comment |
|
12:30 PM |
- Lunch - |
|
2:00 PM |
Other Perspectives on Managing a National Vaccine Supply
Moderator: Bruce Gellin
|
David Salisbury (United Kingdom) [PPT - 1.6MB]
Arlene King (Canada) [PPT - 1.32MB] |
2:45 PM |
Next Steps: Recommendations from Additional Stakeholders
Moderator: Bruce Gellin |
John Clymer (Partnership for Prevention) [PPT - 393KB]
Timothy Doran (American Academy of Pediatrics)
Andrew Pavia (Infectious Disease Society of America) [PPT - 458KMB]
Scott Gottlieb (American Enterprise Institute)
|
3:15 PM |
Discussion & Public Comment |
|
3:45 PM |
Summary and Conclusions |
Jerome Klein (NVAC) |
4:30 PM |
- Adjourn - |
|
Download Reader 
